Skip Navigation

Cardiovascular Research 2002 53(2):313-325; doi:10.1016/S0008-6363(01)00452-7
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Moons, A. H.M
Right arrow Articles by Peters, R. J.G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moons, A. H.M
Right arrow Articles by Peters, R. J.G
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Tissue factor and coronary artery disease

Arno H.M Moonsa, Marcel Levib and Ron J.G Petersa,*

aDepartment of Cardiology, Academic Medical Center, Room F3-236, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
bDepartment of Internal Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands

r.j.peters{at}amc.uva.nl

* Corresponding author. Tel.: +31-20-566-6952; fax: +31-20-566-9747

Plaque disruption with superimposed thrombosis is the main cause of acute coronary events such as acute myocardial infarction and unstable angina. Among other factors, tissue factor seems to play an important role determining plaque thrombogenicity. Tissue factor is a potent initiator of the coagulation cascade situated within the vessel wall and is highly exposed to the blood after plaque rupture. Several mediators involved in the process of atherosclerotic plaque formation are capable of inducing tissue factor expression in cells such as monocytes, macrophages and endothelial cells, which under normal conditions do not express tissue factor or to a limited extent only. The increased expression of tissue factor is not limited to the plaque but is also found in circulating monocytes in patients with acute coronary syndromes. In addition, studies have shown an important contribution of tissue factor in the pathogenesis of thrombosis and restenosis after balloon angioplasty. Recent basic studies focus on the therapeutic inhibition of tissue factor. Specific and non-specific inhibitors of tissue factor or the tissue factor/factor VIIa complex have been developed or identified, and have been tested in experimental studies. Clinical studies are currently being initiated. In this review, we present the current knowledge on the role of tissue factor in atherosclerosis, arterial intervention and potential pharmacological approaches, with focus on acute coronary syndromes.

KEYWORDS Atherosclerosis; Coronary disease; Hemostasis; Thrombosis/embolism

{star} Professor F.W.A. Verheugt acted as a guest editor for this manuscript.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
S. Eligini, F. Violi, C. Banfi, S. S. Barbieri, M. Brambilla, M. Saliola, E. Tremoli, and S. Colli
Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism
Cardiovasc Res, January 1, 2006; 69(1): 218 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. Pandolfi
C-reactive protein: A potential new molecular link between inflammation, thrombosis and vascular cell proliferation?
Cardiovasc Res, October 1, 2005; 68(1): 3 - 4.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.